Nobel Biocare.

Nobel Biocare's story page says the company is headquartered in Zurich and that production takes place at four sites in the United States, Sweden, and Japan, with products available in more than 80 countries. It traces the work to Per-Ingvar Branemark's description of osseointegration in 1952 and to the first titanium implants placed for Gosta Larsson in Gothenburg in 1965. After clinical trials, Branemark and the Swedish company Bofors founded Nobelpharma, which later became Nobel Biocare.

Danaher announced on 15 September 2014 an agreement to acquire Nobel Biocare Holding AG and said the brand would stay a stand-alone company inside Danaher's dental platform, separate from the Implant Direct joint venture. A Dental Tribune report on a Nobel Biocare services page says Danaher completed its separation from Envista in December 2019, and that the dental businesses under Envista included Nobel Biocare, Ormco, and KaVo Kerr. Current ownership questions should be checked against Envista's latest filing, not against the 2014 announcement alone.

The story page names implant systems including NobelActive and NobelParallel, the ceramic implant NobelPearl, NobelProcera prosthetics, and planning software NobelClinician and DTX Studio. The products page also lists All-on-4, NobelReplace, NobelZygoma, On1, Xeal and TiUltra surfaces, and the creos biomaterials line, including xenoprotect membranes and syntogain graft substitute. Those are names on the current product index. A surgical plan still has to name one connection.

The products page also points to motors sold alongside the implants, including OsseoSet 300 and KaVo surgical motors, and to scanners and SprintRay printers as digital options. A motor or a printer is not included because the implant is Nobel. Order the fixture, the abutment, and any graft as separate lines. The products page also lists a conical-connection restorative portfolio, Multi-unit abutments, and the On1 concept for leaving a base at the tissue. Those restorative parts still have to match the implant connection. A lab that receives only a scan body name, such as PoLo on that page, still needs the abutment platform written on the ticket. Training and patient materials are mentioned on the story page and are not components in the surgical cassette. NobelZygoma on the products page is the graftless option the company describes for severe maxillary atrophy, and it is not a routine NobelActive case.

Nobel Biocare suits a surgical practice that will stay inside one Nobel connection and wants the Zurich-based brand's implants and prosthetics. Motors are compared on the implant motor guide.

Grafts placed with the implant are a separate shelf. See the bone grafting guide.

NobelActive, NobelParallel, and NobelPearl are different implants. All-on-4 is a treatment concept named on the products page, not a single SKU. Zygoma fixtures are another indication.

Envista also owns other dental brands. A KaVo motor on the products page is not a Nobel implant. Keep the brand on the box matched to the IFU.

The story page says headquarters are in Zurich and production is at four sites in the United States, Sweden, and Japan. Ask which site made the lot if origin is on your purchasing policy.

The 1965 patient story is history. It is not a warranty. Training is offered, and it is not a component in the surgical kit.